The critical role of mast cells in allergy and inflammation

Annals of the New York Academy of Sciences

Volumn 1088, Issue , 2006, Pages 78-99

  Theoharides, Theoharis C ^a   Kalogeromitros, Dimitrios ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Asthma; Coronary artery disease; Dermatoses; Inflammation; Mast cells; Skin; Stress; Vascular permeability

Indexed keywords

ANAPHYLATOXIN; ANTALARMIN; BIOGENIC AMINE; CHEMOKINE; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; ENZYME; GROWTH FACTOR; IMMUNOGLOBULIN E RECEPTOR; NEUROPEPTIDE; NITRIC OXIDE; PEPTIDE; PHOSPHOLIPID; PROTEOGLYCAN; SUPERANTIGEN;

ALLERGY; ARTHRITIS; ASTHMA; ATOPIC DERMATITIS; CELL ACTIVATION; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DEGRANULATION; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; MAST CELL; NONHUMAN; PATHOGENESIS; SKIN INFLAMMATION; STRESS; ANIMAL; CORONARY ARTERY ATHEROSCLEROSIS; HYPERSENSITIVITY; IMMUNOLOGY; IMMUNOMODULATION; MENTAL STRESS; REVIEW;

ANIMALS; ARTHRITIS; ASTHMA; CORONARY ARTERIOSCLEROSIS; DERMATITIS, ATOPIC; HUMANS; HYPERSENSITIVITY; MAST CELLS; NEUROIMMUNOMODULATION; STRESS, PSYCHOLOGICAL;

EID: 34247512849     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1366.025     Document Type: Conference Paper

References (207)

1. BLANK, U. & J. RIVERA. 2004. The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol. 25: 266-273.
2. KRAFT, S., S. RANA, M.H. JOUVIN, et al. 2004. The role of the FcεRI beta-chain in allergic diseases. Int. Arch. Allergy Immunol. 135: 62-72.
3. 206. Mol. Biol. Cell 9: 875-884.
4. BOESIGER, J., M. TSAI, M. MAURER, et al. 1998. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of Fce receptor I expression. J. Exp. Med. 188: 1135-1145.
5. GALLI, S.J., S. NAKAE & M. TSAI. 2005. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6: 135-142.
6. RODEWALD, H.R., M. DESSING, A.M. DVORAK, et al. 1996. Identification of a committed precursor for the mast cell lineage. Science 271: 818-822.
7. CHEN, C.C., M.A. GRIMBALDESTON, M. TSAI, et al. 2005. Identification of mast cell progenitors in adult mice. Proc. Natl. Acad. Sci. USA 102: 11408-11413.
8. ALOE, L. & R. LEVI-MONTALCINI. 1977. Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res. 133: 358-366.
9. CONTI, P., X. PANG, W. BOUCHER, et al. 1997. Impact of RANTES and MCP-1 chemokines on in vivo basophilic mast cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood 89: 4120-4127.
10. ROTTEM, M. & Y.A. MEKORI. 2005. Mast cells and autoimmunity. Autoimmun. Rev. 4: 21-27.
11. GALLI, S.J., J. KALESNIKOFF, M.A. G RIMBALDESTON, et al. 2005. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23: 749-786.
12. THEOHARIDES, T.C. & D.E. COCHRANE. 2004. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J. Neuroimmunol. 146: 1-12.
13. KRANEVELD, A.D., M. KOOL, A.H. VAN HOUWELINGEN, et al. 2005. Elicitation of allergic asthma by immunoglobulin free light chains. Proc. Natl. Acad. Sci. USA 102: 1578-1583.
14. REDEGELD, F.A., M.W. VAN DER HEIJDEN, M. KOOL, et al. 2002. Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses. Nat. Med. 8: 694-701.
15. REDEGELD, F.A. & F.P. NIJKAMP. 2003. Immunoglobulin free light chains and mast cells: pivotal role in T-cell-mediated immune reactions? Trends Immunol. 24: 181-185.
16. BENOIST, C. & D. MATHIS. 2002. Mast cells in autoimmune disease. Nature 420: 875-878.
17. WOOLLEY, D.E. 2003. The mast cell in inflammatory arthritis. N. Engl. J. Med. 348: 1709-1711.
18. THEOHARIDES, T.C., P.K. BONDY, N.D. TSAKALOS, et al. 1982. Differential release of serotonin and histamine from mast cells. Nature 297: 229-231.
19. THEOHARIDES, T.C. & W.W. DOUGLAS. 1978. Somatostatin induces histamine secretion from rat peritoneal mast cells. Endocrinology 102: 1637-1640.
20. DIMITRIADOU, V., M. LAMBRACHT-HALL, J. REICHLER, et al. 1990. Histochemical and ultrastructural characteristics of rat brain perivascular mast cells stimulated with compound 48/80 and carbachol. Neuroscience 39: 209-224.
21. DIMITRIADOU, V., M.G. BUZZI, M.A. MOSKOWITZ, et al. 1991. Trigeminal sensory fiber stimulation induces morphologic changes reflecting secretion in rat dura mast cells. Neuroscience 44: 97-112.
22. THEOHARIDES, T.C., G.R. SANT, M. EL- MANSOURY, et al. 1995. Activation of bladder mast cells in interstitial cystitis: a light and electron microscopic study. J. Urol. 153: 629-636.
23. LETOURNEAU, R., X. PANG, G.R. SANT, et al. 1996. Intragranular activation of bladder mast cells and their association with nerve processes in interstitial cystitis. Br. J. Urol. 77: 41-54.
24. DVORAK, A.M., R.S. MCLEOD, A. ONDERDONK, et al. 1992. Ultrastructural evidence for piecemeal and anaphylactic degranulation of human gut mucosal mast cells in vivo. Int. Arch. Allergy Immunol. 99: 74-83.
25. KOPS, S.K., H. VAN LOVEREN, R.W. ROSENSTEIN, et al. 1984. Mast cell activation and vascular alterations in immediate hypersensitivity-like reactions induced by a T cell derived antigen-binding factor. Lab. Invest. 50: 421-434.
26. VAN LOVEREN, H., S.K. KOPS & P.W. ASKENASE. 1984. Different mechanisms of release of vasoactive amines by mast cells occur in T cell-dependent compared to IgE-dependent cutaneous hypersensitivity responses. Eur. J. Immunol. 14: 40-47.
27. KOPS, S.K., T.C. THEOHARIDES, C.T. CRONIN, et al. 1990. Ultrastructural characteristics of rat peritoneal mast cells undergoing differential release of serotonin without histamine and without degranulation. Cell Tissue Res. 262: 415-424.
28. BENYON, R., C. ROBINSON & M.K. CHURCH. 1989. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. Br. J. Pharmacol. 97: 898-904.
29. 2 in rat peritoneal mast cells activated with peptides. Int. Arch. Allergy Appl. Immunol. 90: 352-357.
30. 2 in rat peritoneal mast cells: roles of cytosolic calcium and protein tyrosine kinases. Biochim. Biophys. Acta 1265: 79-88.
31. LEAL-BERUMEN, I., P. CONLON & J.S. MARSHALL. 1994. IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J. Immunol. 152: 5468-5476.
32. MARQUARDT, D.L., J.L. ALONGI & L.L. WALKER. 1996. The phosphatidylinositol 3-kinase inhibitor wortmannin blocks mast cell exocytosis but not IL-6 production. J. Immunol. 156: 1942-1945.
33. GAGARI, E., M. TSAI, C.S. LANTZ, et al. 1997. Differential release of mast cell interleukin-6 via c-kit. Blood 89: 2654-2663.
34. HOJO, H., R. SUN, Y. ONO, et al. 1996. Differential production of interleukin-6 and its close relation to liver metastasis in clones from murine P815 mastocytoma. Cancer Lett. 108: 55-59.
35. KANDERE-GRZYBOWSKA, K., R. LETOURNEAU, W. BOUCHER, et al. 2003. IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J. Immunol. 171: 4830-4836.
36. CAO, J., C.L. CURTIS & T.C. THEOHARIDES. 2006. Corticotropin-releasing hormone (CRH) induces vascular endothelial growth factor (VEGF) release from human mast cells via the cAMP/protein kinase A/p38 MAPK pathway Mol. Pharmacol. 69: 998-1006.
37. LEUNG, D.Y., L.A. DIAZ, V. DELEO, et al. 1997. Allergic and immunologic skin disorders. JAMA 278: 1914-1923.
38. CHARLESWORTH, E.N. 1995. Role of basophils and mast cells in acute and late reactions in the skin. Chem. Immunol. 62: 84-107.
39. CHURCH, M.K. & G.F. CLOUGH. 1999. Human skin mast cells: in vitro and in vivo studies. Ann. Allergy Asthma Immunol. 83: 471-475.
40. NOLI, C. & A. MIOLO. 2001. The mast cell in wound healing. Vet. Dermatol. 12: 303-313.
41. JARVIKALLIO, A., I.T. HARVIMA & A. NAUKKARINEN. 2003. Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch. Dermatol. Res. 295: 2-7.
42. WIESNER-MENZEL, L., B. SCHULZ, F. VAKILZADEH, et al. 1981. Electron microscopical evidence for a direct contact between nerve fibers and mast cells. Acta Derm. Venereol. (Stockh) 61: 465-469.
43. GOETZL, E.J., T. CHERNOV, F. RENOLD, et al. 1985. Neuropeptide regulation of the expression of immediate hypersensitivity. J. Immunol. 135: 802s-805s.
44. FOREMAN, J.C. 1987. Neuropeptides and the pathogenesis of allergy. Allergy 42: 1-11.
45. CHURCH, M.K., M.A. LOWMAN, P.H. REES, et al. 1989. Mast cells, neuropeptides and inflammation. Agents Actions 27: 8-16.
46. GOETZL, E.J., P.P.J. CHENG, A. HASSNER, et al. 1990. Neuropeptides, mast cells and allergy: novel mechanisms and therapeutic possibilities. Clin. Exp. Allergy 20: 3-7.
47. CARRAWAY, R., D.E. COCHRANE, J.B. LANSMAN, et al. 1982. Neurotensin stimulates exocytotic histamine secretion from rat mast cells and elevates plasma histamine levels. J. Physiol. 323: 403-414.
48. WATT, F.M. 1991. Cell culture models of differentiation. FASEB J. 5: 287-294.
49. FEWTRELL, C.M.S., J.C. FOREMAN, C.C. JORDAN, et al. 1982. The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J. Physiol. 330: 393-411.
50. ODUM, L., L.J. PETERSEN, P.S. SKOV, et al. 1998. Pituitary adenylate cyclase activating polypeptide (PACAP) is localized in human dermal neurons and causes histamine release from skin mast cells. Inflamm. Res. 47: 488-492.
51. TOYODA, M., T. MAKINO, M. KAGOURA, et al. 2000. Immunolocalization of substance P in human skin mast cells. Arch. Dermatol. Res. 292: 418-421.
52. XIANG, Z. & G. NILSSON. 2000. IgE receptor-mediated release of nerve growth factor by mast cells. Clin. Exp. Allergy 30: 1379-1386.
53. SLOMINSKI, A. & J. WORTSMAN. 2000. Neuroendocrinology of the skin. Endocr. Rev. 21: 457-487.
54. SLOMINSKI, A., J. WORTSMAN, T. LUGER, et al. 2000. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol. Rev. 80: 979-1020.
55. SLOMINSKI, A., J. WORTSMAN, A. PISARCHIK, et al. 2001. Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J. 15: 1678-1693.
56. LYTINAS, M., D. KEMPURAJ, M. HUANG, et al. 2003. Acute stress results in skin corticotropin-releasing hormone secretion, mast cell activation and vascular permeability, an effect mimicked by intradermal corticotropin-releasing hormone and inhibited by histamine-1 receptor antagonists. Int. Arch. Allergy Immunol. 130: 224-231.
57. DHABHAR, F. & B.S. MCEWEN. 1996. Stress-induced enhancement of antigen-specific cell-mediated immunity. J. Immunol. 156: 2608-2615.
58. DHABHAR, F.S. & B.S. MCEWEN. 1999. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc. Natl. Acad. Sci. USA 96: 1059-1064.
59. KANEKO, K., S. KAWANA, K. ARAI, et al. 2003. Corticotropin-releasing factor receptor type 1 is involved in the stress-induced exacerbation of chronic contact dermatitis in rats. Exp. Dermatol. 12: 47-52.
60. KIMATA, H. 2003. Enhancement of allergic skin wheal responses and in vitro allergen-specific IgE production by computer-induced stress in patients with atopic dermatitis. Brain Behav. Immun. 17: 134-138.
61. KIMATA, H. 2003. Enhancement of allergic skin wheal responses in patients with atopic eczema/dermatitis syndrome by playing video games or by a frequently ringing mobile phone. Eur. J Clin. Invest 33: 513-517.
62. CHOI, I.S., Y.I. KOH, S.W. CHUNG, et al. 2004. Increased releasability of skin mast cells after exercise in patients with exercise-induced asthma. J. Korean Med. Sci. 19: 724-728.
63. THEOHARIDES, T.C., L.K. SINGH, W. BOUCHER, et al. 1998. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its pro-inflammatory effects. Endocrinology 139: 403-413.
64. SINGH, L.K., W. BOUCHER, X. PANG, et al. 1999. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of CRH receptors. J. Pharmacol. Exp. Ther. 288: 1349-1356.
65. CLIFTON, V.L., R. CROMPTON, R. SMITH, et al. 2002. Microvascular effects of CRH in human skin vary in relation to gender. J. Clin. Endocrinol. Metab. 87: 267-270.
66. KATSAROU-KATSARI, A., L.K. SINGH & T.C. THEOHARIDES. 2001. Alopecia areata and affected skin CRH receptor upregulation induced by acute emotional stress. Dermatology 203: 157-161.
67. PAPADOPOULOU, N., D. KALOGEROMITROS, N.G. STAURIANEAS, et al. 2005. Corticotropin-releasing hormone receptor-1 and histidine decarboxylase expression in chronic urticaria. J. Invest. Dermatol. 125: 952-955.
68. SINGH, L.K., X. PANG, N. ALEXACOS, et al. 1999. Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin and substance P: a link to neurogenic skin disorders. Brain Behav. Immun. 13: 225-239.
69. CARRAWAY, R.E., D.E. COCHRANE, W. BOUCHER, et al. 1989. Structures of histamine-releasing peptides formed by the action of acid proteases on mammalian albumin(s). J. Immunol. 143: 1680-1684.
70. COCHRANE, D.E., R.E. CARRAWAY, R.S. FELDBERG, et al. 1993. Stimulated rat mast cells generate histamine-releasing peptide from albumin. Peptides 14: 117-123.
71. SCHMIDLIN, F. & N.W. BUNNETT. 2001. Protease-activated receptors: how proteases signal to cells. Curr. Opin. Pharmacol. 1: 575-582.
72. MOLINO, M., E.S. BARNATHAN, R. NUMEROF, et al. 1997. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J. Biol. Chem. 272: 4043-4049.
73. KATSAROU-KATSARI, A., A. FILIPPOU & T.C. THEOHARIDES. 1999. Effect of stress and other psychological factors on the pathophysiology and treatment of dermatoses. Int. J. Immunopathol. Pharmacol. 12: 7-11.
74. GRAHAM, D.T. & S. WOLF. 1953. The relation of eczema to attitude and to vascular reactions of the human skin. J. Lab. Clin. Med. 42: 238-254.
75. MURPHY, P.M. 2001. Chemokines and the molecular basis of cancer metastasis. N. Engl. J. Med. 345: 833-835.
76. THEOHARIDES, T.C., C.P. SPANOS, X. PANG, et al. 1995. Stress-induced intracranial mast cell degranulation. A corticotropin releasing hormone-mediated effect. Endocrinology 136: 5745-5750.
77. CAO, J., N. PAPADOPOULOU, D. KEMPURAJ, et al. 2005. Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor (VEGF). J. Immunol. 174: 7665-7675.
78. POLLARD, H., S. BISCHOFF, C. LLORENS- CORTES, et al. 1976. Histidine decarboxylase and histamine in discrete nuclei of rat hypothalamus and the evidence for mast cells in the median eminence. Brain Res. 118: 509-513.
79. PANULA, P., H.-Y.T. YANG & E. COSTA. 1984. Histamine-containing neurons in the rat hypothalamus. Proc. Natl. Acad. Sci. USA 81: 2572-2576.
80. YAMATODANI, A., K. MAEYAMA, T. WATANABE, et al. 1982. Tissue distribution of histamine in a mutant mouse deficient in mast cells: clear evidence for the presence of non-mast cell histamine. Biochem. Pharmacol. 31: 305-309.
81. BUGAJSKI, A.J., Z. CHLAP, A. GADEK- MICHALSKA, et al. 1995. Degranulation and decrease in histamine levels of thalamic mast cells coincides with corticosterone secretion induced by compound 48/80. Inflamm. Res. 44(Supp.1): S50-S51.
82. GADEK-MICHALSKA, A., Z. CHLAP, M. TURON, et al. 1991. The intracerebroventricularly administered mast cells degranulator compound 48/80 increases the pituitary-adrenocortical activity in rats. Agents Actions 32: 203-208.
83. MATSUMOTO, I., Y. INOUE, T. SHIMADA, et al. 2001. Brain mast cells act as an immune gate to the hypothalamic- pituitary-adrenal axis in dogs. J. Exp. Med. 194: 71-78.
84. ROBERTS, F. & C.R. CALCUTT. 1983. Histamine and the hypothalamus. Neuroscience 9: 721-739.
85. 2 receptors. Eur. J. Endocrinol. 139: 238-243.
86. KEMPURAJ, D., N.G. PAPADOPOULOU, M. LYTINAS, et al. 2004. Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology 145: 43-480; Epub 2003 Oct. 23.
87. BETHIN, K.E., S.K. VOGT & L.J. MUGLIA. 2000. Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc. Natl. Acad. Sci. USA 97: 9317-9322.
88. BUSKE-KIRSCHBAUM, A. & D.H. HELLHAMMER. 2003. Endocrine and immune responses to stress in chronic inflammatory skin disorders. Ann. N. Y. Acad. Sci. 992: 231-240.
89. PAUS, R., T.C. THEOHARIDES & P.C. ARCK. 2006. Neuroimmunoendocrine circuitry of the "brain-skin connection." Trends Immunol 27: 32-39.
90. CRISP, A.J., C.M. CHAMPAN, S.E. KIRKHAM, et al. 1984. Articular mastocytosis in rheumatoid arthritis. Arthritis Rheum. 27: 845-851.
91. KOLDEWIJN, E.L., O.R. HOMMES, W.A.J.G. LEMMENS, et al. 1995. Relationship between lower urinary tract abnormalities and disease-related parameters in multiple sclerosis. J. Urol. 154: 169-173.
92. WOOLLEY, D.E. 1995. Mast cells in the rheumatoid lesion - ringleaders or innocent bystanders. Ann. Rheum. Dis. 54: 533-534.
93. TETLOW, L.C. & D.E. WOOLLEY. 1995. Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion. Ann. Rheum. Dis. 54: 549-555.
94. DE PAULIS, A., A. CICCARELLI, I. MARINÒ, et al. 1997. Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs. Arthritis Rheum. 40: 469-478.
95. DE PAULIS, A., I. MARINO, A. CICCARELLI, et al. 1996. Human synovial mast cells. I. Utrastructural in situ and in vitro immunologic characterization. Arthritis Rheum. 39: 1222-1233.
96. GOTIS-GRAHAM, I., M.D. SMITH, A. PARKER, et al. 1998. Synovial mast cell responses during clinical improvement in early rheumatoid arthritis. Ann. Rheum. Dis. 57: 664-671.
97. CONTI, P., M. REALE, R.C. BARBACANE, et al. 2002. Differential production of RANTES and MCP-1 in synovial fluid from the inflamed human knee. Immunol. Lett. 80: 105-111.
98. LEE, D.M., D.S. FRIEND, M.F. GURISH, et al. 2002. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297: 1689-1692.
99. MATTHEOS, S., S. CHRISTODOULOU, D. KEMPURAJ, et al. 2003. Mast cells and corticotropin-releasing hormone (CRH) are required for experimental inflammatory arthritis. FASEB J. 17: C44.
100. WEBSTER, E.L., R.M. BARRIENTOS, C. CONTOREGGI, et al. 2002. Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation. J. Rheumatol. 29: 1252-1261.
101. MCEVOY, A.N., B. BRESNIHAN, O. FITZGERALD, et al. 2001. Corticotropin-releasing hormone signaling in synovial tissue from patients with early inflammatory arthritis is mediated by the type 1a corticotropin-releasing hormone receptor. Arthritis Rheum. 44: 1761-1767.
102. LOWRY, P.J., R.J. WOODS & S. BAIGENT. 1996. Corticotropin releasing factor and its binding protein. Pharmacol. Biochem. Behav. 54: 305-308.
103. UZUKI, M., H. SASANO, Y. MURAMATSU, et al. 2001. Urocortin in the synovial tissue of patients with rheumatoid arthritis. Clin. Sci. 100: 577-589.
104. KOHNO, M., Y. KAWAHITO, Y. TSUBOUCHI, et al. 2001. Urocortin expression in synovium of patients with rheumatoid arthritis and osteoarthritis: relation to inflammatory activity. J. Clin. Endocrinol. Metab. 86: 4344-4352.
105. THOMASON, B.T., P.J. BRANTLEY, G.N. JONES, et al. 1992. The relation between stress and disease activity in rheumatoid arthritis. J. Behav. Med. 15: 215-220.
106. HERRMANN, M., J. SCHOLMERICH & R.H. STRAUB. 2000. Stress and rheumatic diseases. Rheum. Dis. Clin. North Am. 26: 737-763.
107. WEISS, S.T. 2001. Epidemiology and heterogeneity of asthma. Ann. Allergy Asthma Immunol. 87: 5-8.
108. PAPIRIS, S., A. KOTANIDOU, K. MALAGARI, et al. 2002. Clinical review: severe asthma. Crit. Care 6: 30-44.
109. LAUBE, B.L., B.A. CURBOW & R.W. COSTELLO. 2002. A pilot study examining the relationship between stress and serum cortisol concentrations in women with asthma. Respir. Med. 96: 823-828.
110. SCHMALING, K.B., P.E. MCKNIGHT & N. AFARI. 2002. A prospective study of the relationship of mood and stress to pulmonary function among patients with asthma. J. Asthma 39: 501-510.
111. KILPELAINEN, M., M. KOSKENVUO, H. HELENIUS, et al. 2002. Stressful life events promote the manifestation of asthma and atopic diseases. Clin. Exp. Allergy 32: 256-263.
112. LAWRENCE, D.A. 2002. Psychologic stress and asthma: neuropeptide involvement. Environ. Health Perspect. 110: A230-A231.
113. BIENENSTOCK, J. 2002. Stress and asthma: the plot thickens. Am. J. Respir. Crit. Care Med. 165: 1034-1035.
114. JOACHIM, R.A., D. QUARCOO, P.C. ARCK, et al. 2003. Stress enhances airway reactivity and airway inflammation in an animal model of allergic bronchial asthma. Psychosom. Med. 65: 811-815.
115. VON HERTZEN, L.C. 2002. Maternal stress and T-cell differentiation of the developing immune system: possible implications for the development of asthma and atopy. J. Allergy Clin. Immunol. 109: 923-928.
116. DENDORFER, U., P. OETTGEN & T.A. LIBERMANN. 1994. Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol. Cell Biol. 14: 4443-4454.
117. LIU, L.Y., C.L. COE, C.A. SWENSON, et al. 2002. School examinations enhance airway inflammation to antigen challenge. Am. J. Respir. Crit. Care Med. 165: 1062-1067.
118. GORDON, D.J. & B.M. RIFKIND. 1989. High-density lipoprotein - the clinical implications of recent studies. N. Engl. J. Med. 321: 1311-1316.
119. CHEN, E., E.B. FISHER, L.B. BACHARIER, et al. 2003. Socioeconomic status, stress, and immune markers in adolescents with asthma. Psychosom. Med. 65: 984-992.
120. WRIGHT, R.J., H. MITCHELL, C.M. VISNESS, et al. 2004. Community violence and asthma morbidity: the Inner-City Asthma Study. Am. J. Public Health 94: 625-632.
121. FAGAN, J., S. GALEA, J. AHERN, et al. 2003. Relationship of self-reported asthma severity and urgent health care utilization to psychological sequelae of the September 11, 2001 terrorist attacks on the World Trade Center among New York City area residents. Psychosom. Med. 65: 993-996.
122. CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC). 2002. Self-reported increase in asthma severity after the September 11 attacks on the World Trade Center - Manhattan, New York, 2001 MMWR 51: 781-784.
123. SMITH, A. & K. NICHOLSON. 2001. Psychosocial factors, respiratory viruses and exacerbation of asthma. Psychoneuroendocrinology 26: 411-420.
124. HASLER, G., P.J. GERGEN, D.G. KLEINBAUM, et al. 2005. Asthma and panic in young adults: a 20-year prospective community study. Am. J. Respir. Crit. Care Med. 171: 1224-1230.
125. WRIGHT, R.J., S. COHEN, V. CAREY, et al. 2002. Parental stress as a predictor of wheezing in infancy: a prospective birth-cohort study. Am. J. Respir. Crit. Care Med. 165: 358-365.
126. KAPOOR, U., G. TAYAL, S.K. MITTAL, et al. 2003. Plasma cortisol levels in acute asthma. Indian J. Pediatr. 70: 965-968.
127. BUSKE-KIRSCHBAUM, A., K. VON AUER, S. KRIEGER, et al. 2003. Blunted cortisol responses to psychosocial stress in asthmatic children: a general feature of atopic disease? Psychosom. Med. 65: 806-810.
128. KIPS, J.C., G.P. ANDERSON, J.J. FREDBERG, et al. 2003. Murine models of asthma. Eur. Respir. J. 22: 374-382.
129. LLOYD, C.M. & J.C. GUTIERREZ-RAMOS. 2004. Animal models to study chemokine receptor function: in vivo mouse models of allergic airway inflammation. Methods Mol. Biol. 239: 199-210.
130. WILSON, J. 2000. The bronchial microcirculation in asthma. Clin. Exp. Allergy 30: 51-53.
131. OLIVENSTEIN, R., T. DU, L.J. XU, et al. 1997. Microvascular leakage in the airway wall and lumen during allergen induced early and late responses in rats. Pulm. Pharmacol. Ther. 10: 223-230.
132. VAN RENSEN, E.L., P.S. HIEMSTRA, K.F. RABE, et al. 2002. Assessment of microvascular leakage via sputum induction: the role of substance P and neurokinin A in patients with asthma. Am. J. Respir. Crit. Care Med. 165: 1275-1279.
133. JOHNSON, J.R., R.E. WILEY, R. FATTOUH, et al. 2004. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am. J. Respir. Crit. Care Med. 169: 378-385.
134. NAURECKAS, E.T., I.M. NDUKWU, A.J. HALAYKO, et al. 1999. Bronchoalveolar lavage fluid from asthmatic subjects is mitogenic for human airway smooth muscle. Am. J. Respir. Crit. Care Med. 160: 2062-2066.
135. SADAKANE, K., T. ICHINOSE, H. TAKANO, et al. 2002. Murine strain differences in airway inflammation induced by diesel exhaust particles and house dust mite allergen. Int. Arch. Allergy Immunol. 128: 220-228.
136. FORSYTHE, P., C. EBELING, J.R. GORDON, et al. 2004. Opposing effects of short-and long-term stress on airway inflammation. Am. J. Respir. Crit. Care Med. 169: 220-226.
137. CHO, S.H., A.J. ANDERSON & C.K. OH. 2002. Importance of mast cells in the pathophysiology of asthma. Clin. Rev. Allergy Immunol. 22: 161-174.
138. BRADDING, P. 2003. The role of the mast cell in asthma: a reassessment. Curr. Opin. Allergy Clin. Immunol. 3: 45-50.
139. BRIGHTLING, C.E., P. BRADDING, I.D. PAVORD, et al. 2003. New insights into the role of the mast cell in asthma. Clin. Exp. Allergy 33: 550-556.
140. VARADARADJALOU, S., F. FEGER, N. THIEBLEMONT, et al. 2003. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur. J. Immunol. 33: 899-906.
141. MCCURDY, J.D., T.J. OLYNYCH, L.H. MAHER, et al. 2003. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J. Immunol. 170: 1625-1629.
142. ROCK, F.L., G. HARDIMAN, J.C. TIMANS, et al. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 95: 588-593.
143. AKIRA, S., K. TAKEDA & T. KAISHO. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2: 675-680.
144. ADEREM, A. & R.J. ULEVITCH. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406: 782-787.
145. HEINE, H. & E. LIEN. 2003. Toll-like receptors and their function in innate and adaptive immunity. Int. Arch. Allergy Immunol. 130: 180-192.
146. CRISTOFARO, P. & S.M. OPAL. 2006. Role of toll-like receptors in infection and immunity: clinical implications. Drugs 66: 15-29.
147. ANTHONY, M. & J.W. LANCE. 1971. Whole blood histamine and plasma serotonin in cluster headache. Proc. Aust. Assoc. Neurol. 8: 43-46.
148. CAIRNS, J.A. & A.F. WALLS. 1996. Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J. Immunol. 156: 275-283.
149. MASUDA, A., Y. YOSHIKAI, K. AIBA, et al. 2002. Th2 cytokine production from mast cells is directly induced by lipopolysaccharide and distinctly regulated by c-Jun N-terminal kinase and p38 pathways. J. Immunol. 169: 3801-3810.
150. SUPAJATURA, V., H. USHIO, A. NAKAO, et al. 2002. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J. Clin. Invest. 109: 1351-1359.
151. IKEDA, R.K., M. MILLER, J. NAYAR, et al. 2003. Accumulation of peribronchial mast cells in a mouse model of ovalbumin allergen induced chronic airway inflammation: modulation by immunostimulatory DNA sequences. J. Immunol. 171: 4860-4867.
152. KULKA, M., L. ALEXOPOULOU, R.A. FLAVELL, et al. 2004. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J. Allergy Clin. Immunol. 114: 174-182.
153. O'SULLIVAN, S.M. 2005. Asthma death, CD8+ T cells, and viruses. Proc. Am. Thorac. Soc. 2: 162-165.
154. DAKHAMA, A., Y.M. LEE & E.W. GELFAND. 2005. Virus-induced airway dysfunction: pathogenesis and biomechanisms. Pediatr. Infect. Dis. J. 24: S159-S169, discussion.
155. VAN RIJT, L.S., C.H. VAN KESSEL, I. BOOGAARD, et al. 2005. Respiratory viral infections and asthma pathogenesis: a critical role for dendritic cells? J. Clin. Virol. 34: 161-169.
156. SACKESEN, C., A. PINAR, B.E. SEKEREL, et al. 2005. Use of polymerase chain reaction for detection of adenovirus in children with or without wheezing Turk. J. Pediatr. 47: 227-231.
157. PELAIA, G., A. VATRELLA, L. GALLELLI, et al. 2006. Respiratory infections and asthma. Respir. Med. 100: 775-784.
158. MATSUSE, H., Y. KONDO, S. SAEKI, et al. 2005. Naturally occurring parainfluenza virus 3 infection in adults induces mild exacerbation of asthma associated with increased sputum concentrations of cysteinyl leukotrienes. Int. Arch. Allergy Immunol. 138: 267-272.
159. WILLIAMS, J.V., J.E. CROWE JR., R. ENRIQUEZ, et al. 2005. Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults. J. Infect. Dis. 192: 1149-1153.
160. LEMANSKE, R.F. JR., D.J. JACKSON, R.E. GANGNON, et al. 2005. Rhinovirus illnesses during infancy predict subsequent childhood wheezing J. Allergy Clin. Immunol. 116: 571-577.
161. KRISTJANSSON, S., S.P. BJARNARSON, G. WENNERGREN, et al. 2005. Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response. J. Allergy Clin. Immunol. 116: 805-811.
162. GUALANO, R.C., R. VLAHOS & G.P. ANDERSON. 2006. What is the contribution of respiratory viruses and lung proteases to airway remodelling in asthma and chronic obstructive pulmonary disease? Pulm. Pharmacol. Ther. 19: 18-23.
163. EDWARDS, M.R., T. KEBADZE, M.W. JOHNSON, et al. 2006. New treatment regimes for virus-induced exacerbations of asthma. Pulm. Pharmacol. Ther. 19: 320-334.
164. DEEDWANIA, P.C. 1995. Mental stress, pain perception and risk of silent ischemia. J. Am. Coll. Cardiol. 25: 1504-1506.
165. FREEMAN, L.J., P.G.F. NIXON, P. SALLABANK, et al. 1987. Psychological stress and silent myocardial ischemia. Am. Heart J. 114: 477-482.
166. DEANFIELD, J.E., M. SHEA, M. KENSETT, et al. 1984. Silent myocardial ischaemia due to mental stress. Lancet 2: 1001-1005.
167. ROZANSKI, A., C.N. BAIREY, D.S. KRANTZ, et al. 1988. Mental stress and the induction of silentmyocardial ischemia in patients with coronary artery disease. N. Engl. J. Med. 318: 1005-1012.
168. PATELLA, V., G. DE CRESCENZO, A. CICCARELLI, et al. 1995. Human heart mast cells: a definitive case of mast cell heterogeneity. Int. Arch. Allergy Immunol. 106: 386-393.
169. FORMAN, M.B., J.A. OATES, D. ROBERTSON, et al. 1985. Increased adventitial mast cells in a patient with coronary spasm. N. Engl. J. Med. 313: 1138-1141.
170. KAARTINEN, M., A. PENTTILÄ & P.T. KOVANEN. 1994. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 90: 1669-1678.
171. CONSTANTINIDES, P. 1995. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 92: 1083-1088.
172. LAINE, P., M. KAARTINEN, A. PENTTILÄ, et al. 1999. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation 99: 361-369.
173. JENNE, D.E. & J. TSCHOPP. 1991. Angiotensin II-forming heart chymase is a mast-cell-specific enzyme. Biochem. J. 276: 567.
174. LEE, M., P.T. KOVANEN, G. TEDESCHI, et al. 2003. Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux. J. Lipid Res. 44: 539-546.
175. LEE, M., L. CALABRESI, G. CHIESA, et al. 2002. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 22: 1475-1481.
176. KOVANEN, P.T. 1996. Mast cells in human fatty streaks and atheromas: implications for intimal lipid accumulation Curr. Opin. Lipidol. 7: 281-286.
177. LINDSTEDT, L., M. LEE, G.R. CASTRO, et al. 1996. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid. J. Clin. Invest. 97: 2174-2182.
178. GRISTWOOD, R.W., J.C. LINCOLN, D.A. OWEN, et al. 1981. Histamine release from human right atrium. Br. J. Pharmacol. 74: 7-9.
179. GENOVESE, A. & G. SPADARO. 1997. Highlights in cardiovascular effects of histamine and H1-receptor antagonists. Allergy 52: 67-78.
180. CHRISTIAN, E.P., B.J. UNDEM & D. WEINREICH. 1989. Endogenous histamine excites neurones in the guinea pig superior cervical ganglion in vitro. J. Physiol. 409: 297-312.
181. LAINE, P., A. NAUKKARINEN, L. HEIKKILA, et al. 2000. Adventitial mast cells connect with sensory nerve fibers in atherosclerotic coronary arteries. Circulation 101: 1665-1669.
182. PANG, X., N. ALEXACOS, R. LETOURNEAU, et al. 1998. A neurotensin receptor antagonist inhibits acute immobilization stress-induced cardiac mast cell degranulation, a corticotropin-releasing hormone-dependent process. J. Pharm. Exp. Ther. 287: 307-314.
183. HUANG, M., X. PANG, L. LETOURNEAU, et al. 2002. Acute stress induces cardiac mast cell activation and histamine release, effects that are increased in apolipoprotein E knockout mice. Cardiovasc. Res. 55: 150-160.
184. HUANG, M., X. PANG, K. KARALIS, et al. 2003. Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice. Cardiovasc. Res. 59: 241-249.
185. DELIARGYRIS, E.N., R.J. RAYMOND, T.C. THEOHARIDES, et al. 2000. Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure. Am. J. Cardiol. 86: 913-918.
186. CLEJAN, S., S. JAPA, C. CLEMETSON, et al. 2002. Blood histamine is associated with coronary artery disease, cardiac events and severity of inflammation and atherosclerosis. J. Cell Mol. Med. 6: 583-592.
187. SUZUKI, M., S. INABA, T. NAGAI, et al. 2003. Relation of C-reactive protein and interleukin-6 to culprit coronary artery plaque size in patients with acute myocardial infarction. Am. J. Cardiol. 91: 331-333.
188. KOUNIS, N.G. & G.M. ZAVRAS. 1996. Allergic angina and allergic myocardial infarction. Circulation 94: 1789.
189. KOUNIS, N.G., N.D. GRAPSAS & J.A. GOUDEVENOS. 1999. Unstable angina, allergic angina, and allergic myocardial infarction. Circulation 100: e156.
190. THEOHARIDES, T.C., J.M. DONELAN, N. PAPADOPOULOU, et al. 2004. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol. Sci. 25: 563-568.
191. THEOHARIDES, T.C. 2003. Dietary supplements for arthritis and other inflammatory conditions: key role of mast cells and benefit of combining antiinflammatory and proteoglycan products. Eur. J. Inflamm. 1: 1-8.
192. THEOHARIDES, T.C., P. PATRA, W. BOUCHER, et al. 2000. Chondroitin sulfate inhibits connective tissue mast cells. Br. J. Pharmacol. 131: 1039-1049.
193. MIDDLETON, E. JR., C. KANDASWAMI & T.C. THEOHARIDES. 2000. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol. Rev. 52: 673-751.
194. HOGABOAM, C.M., A.D. BEFUS & J.L. WALLACE. 1993. Modulation of rat mast cell reactivity by IL-1 beta. Divergent effects on nitric oxide and platelet-activating factor release. J. Immunol. 151: 3767-3774.
195. LEAL-BERUMEN, I., P. O'BYRNE, A. GUPTA, et al. 1995. Prostanoid enhancement of interleukin-6 production by rat peritoneal mast cells. J. Immunol. 154: 4759-4767.
196. GUPTA, A.A., I. LEAL-BERUMEN, K. CROITORU, et al. 1996. Rat peritoneal mast cells produce IFN-γ following IL-12 treatment but not in response to IgE-mediated activation. J. Immunol. 157: 2123-2128.
197. LIN, T.J., N. HIRJI, O. NOHARA, et al. 1998. Mast cells express novel CD8 molecules that selectively modulate mediator secretion. J. Immunol. 161: 6265-6272.
198. GORDON, J.R., X. ZHANG, K. STEVENSON, et al. 2000. Thrombin induces IL-6 but not TNFα secretion by mouse mast cells: threshold-level thrombin receptor and very low level FceRI signaling synergistically enhance IL-6 secretion. Cell Immunol. 205: 128-135.
199. LIN, T.J., T.B. ISSEKUTZ & J.S. MARSHALL. 2000. Human mast cells transmigrate through human umbilical vein endothelial monolayers and selectively produce IL-8 in response to stromal cell-derived factor-1 alpha. J. Immunol. 165: 211-220.
200. KALESNIKOFF, J., M. HUBER, V. LAM, et al. 2001. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 801-811.
201. COULOMBE, M., B. BATTISTINI, J. STANKOVA, et al. 2002. Endothelins regulate mediator production of rat tissue-cultured mucosal mast cells. Up-regulation of Th1 and inhibition of Th2 cytokines. J. Leukoc. Biol. 71: 829-836.
202. MELLOR, E.A., K.F. AUSTEN & J.A. BOYCE. 2002. Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. J. Exp. Med. 195: 583-592.
203. PAPADOPOULOU, N.G., L. OLESON, D. KEMPURAJ, et al. 2005. Regulation of corticotropin-releasing hormone receptor-2 expression in human cord blood-derived cultured mast cells. J. Mol. Endocrinol. 35: R1-R8.
204. ZHU, F., K. GOMI & J.S. MARSHALL. 1998. Short-term and long-term cytokine release by mouse bone marrow mast cells and the differentiated KU-812 cell line are inhibited by brefeldin A. J. Immunol. 161: 2541-2551.
205. LEAL-BERUMEN, I., D.P. SNIDER, C. BARAJAS-LOPEZ, et al. 1996. Cholera toxin increases IL-6 synthesis and decreases TNF-α production by rat peritoneal mast cells. J. Immunol. 156: 316-321.
206. CALDERON, G.M., J. TORRES-LOPEZ, T.J. LIN, et al. 1998. Effects of toxin A from Clostridium difficile on mast cell activation and survival. Infect. Immun. 66: 2755-2761.
207. GONZALEZ-ESPINOSA, C., S. ODOM, A. OLIVERA, et al. 2003. Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells. J. Exp. Med. 197: 1453-1465.